Skip to content

Establishment of predictive cutoff points for urate joint deposition and research on intervention strategies

Establishment of predictive cutoff points for urate joint deposition and research on intervention strategies

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081817
Enrollment
Unknown
Registered
2024-03-13
Start date
2024-04-14
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout and hyperuricemia

Interventions

positive group:Uric acid lowering therapy
negative group:No treatment

Sponsors

The 967th Hospital of P.L.A
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Meeting the diagnostic criteria for hyperuricemia; (2) Agree to participate in this study; (3) Not taking any hormone drugs or other drugs that affect the study for at least 3 months before enrollment; (4) The underlying disease is stable and does not affect treatment and observation; (5) Age = 18 years old; (6) Approved and approved by the hospital ethics committee.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Existence of intellectual, mental, cognitive, or other neurological impairments; (2) Taking medication that affects treatment and observation; (3) Severe underlying diseases; (4) Acidosis; (5) Heart failure.

Design outcomes

Primary

MeasureTime frame
Dual energy CT examination of joints;

Countries

China

Contacts

Public ContactXue Li

The 967th Hospital of P.L.A

yeshengkai@163.com+86 411 8084 1197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026